(Circulation. 2001;104:2734.)
© 2001 American Heart Association, Inc.
Basic Science Reports |
From the Department of Cardiology, Childrens Hospital (C.I.B., H.W., C.T.M., M.M.V., J.G.), the Department of Genetics, Howard Hughes Medical Institute (B.K.M., C.S., C.E.S., J.G.S.), the Department of Pathology, Childrens Hospital (I.P.G.M.), and Harvard Medical School (C.I.B., B.K.M., I.P.G.M., C.S., C.E.S., J.G.S.), Boston, Mass.
Correspondence to Charles I. Berul, MD, Department of Cardiology, Childrens Hospital Boston, 300 Longwood Ave, Boston, MA 02115. E-mail berul{at}cardio.tch.harvard.edu
Background Homozygous mutant mice expressing a truncated form of myosin-binding protein C (MyBP-Ct/t) develop severe dilated cardiomyopathy, whereas the heterozygous mutation (MyBP-Ct/+) causes mild hypertrophic cardiomyopathy. Adult male MyBP-Ct/t and MyBP-Ct/+ mice were evaluated for arrhythmia vulnerability with an in vivo electrophysiology study.
Methods and Results Surface ECGs were obtained for heart rate, rhythm, and conduction intervals. Atrial, atrioventricular, and ventricular conduction parameters and refractoriness were assessed in 22 MyBP-Ct/t, 10 MyBP-Ct/+, and 17 wild-type MyBP-C+/+ mice with endocardial pacing and intracardiac electrogram recording. Arrhythmia induction was attempted with standardized programmed stimulation at baseline and with isoproterenol. Heart rate variability and ambient arrhythmia activity were assessed with telemetric ECG monitors. Quantitative histological characterization was performed on serial sections of excised hearts. MyBP-Ct/t and MyBP-Ct/+ mice have normal ECG intervals and sinus node, atrial, and ventricular conduction and refractoriness. Ventricular tachycardia was reproducibly inducible in 14 of 22 MyBP-Ct/t mice (64%) during programmed stimulation, compared with 2 of 10 MyBP-Ct/+ mice (20%) and 0 of 17 wild-type controls (P<0.001). Ventricular ectopy was present only in MyBP-Ct/t mice during ambulatory ECG recordings. There were no differences in heart rate variability parameters. Interstitial fibrosis correlated with genotype but did not predict arrhythmia susceptibility within the MyBP-Ct/t group.
Conclusions MyBP-Ct/t mice, despite prominent histopathology and ventricular dysfunction, exhibit normal conduction and refractoriness, yet are vulnerable to ventricular arrhythmias. Somatic influences between genetically identical mutant mice most likely account for variability in arrhythmia susceptibility. A sarcomeric protein gene mutation leads to a dilated cardiomyopathy and ventricular arrhythmia vulnerability phenotype.
Key Words: arrhythmia cardiomyopathy electrophysiology genetics pathology
This article has been cited by other articles:
![]() |
J. W. Schrickel, K. Brixius, C. Herr, C. S. Clemen, P. Sasse, K. Reetz, C. Grohe, R. Meyer, K. Tiemann, R. Schroder, et al. Enhanced heterogeneity of myocardial conduction and severe cardiac electrical instability in annexin A7-deficient mice Cardiovasc Res, November 1, 2007; 76(2): 257 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Thomas, I. S. Gurung, M. J. Killeen, P. Hakim, C. A. Goddard, M. P. Mahaut-Smith, W. H. Colledge, A. A. Grace, and C. L.-H. Huang Effects of L-type Ca2+ channel antagonism on ventricular arrhythmogenesis in murine hearts containing a modification in the Scn5a gene modelling human long QT syndrome 3 J. Physiol., January 1, 2007; 578(1): 85 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ahmad, M. Arad, N. Musi, H. He, C. Wolf, D. Branco, A. R. Perez-Atayde, D. Stapleton, D. Bali, Y. Xing, et al. Increased {alpha}2 Subunit-Associated AMPK Activity and PRKAG2 Cardiomyopathy Circulation, November 15, 2005; 112(20): 3140 - 3148. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Milan and C. A. MacRae Animal models for arrhythmias Cardiovasc Res, August 15, 2005; 67(3): 426 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Gillis, K. M. Kavanagh, H. J. Mathison, J. R. Somers, S. Zhan, and H. J. Duff Heart block in mice overexpressing calcineurin but not NF-AT3 Cardiovasc Res, December 1, 2004; 64(3): 488 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. P. G. Moskowitz, A. Pizard, V. V. Patel, B. G. Bruneau, J. B. Kim, S. Kupershmidt, D. Roden, C. I. Berul, C. E. Seidman, and J. G. Seidman The T-Box transcription factor Tbx5 is required for the patterning and maturation of the murine cardiac conduction system Development, August 15, 2004; 131(16): 4107 - 4116. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Maguire, H. Wakimoto, V. V. Patel, P. E. Hammer, K. Gauvreau, and C. I. Berul Implications of ventricular arrhythmia vulnerability during murine electrophysiology studies Physiol Genomics, September 29, 2003; 15(1): 84 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. V. Patel, M. Arad, I. P. G. Moskowitz, C. T. Maguire, D. Branco, J. G. Seidman, C. E. Seidman, and C. I. Berul Electrophysiologic characterization and postnatal development of ventricular pre-excitation in a mouse model of cardiachypertrophy and Wolff-Parkinson-White syndrome J. Am. Coll. Cardiol., September 3, 2003; 42(5): 942 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Gutstein, S. B. Danik, J. B. Sereysky, G. E. Morley, and G. I. Fishman Subdiaphragmatic murine electrophysiological studies: sequential determination of ventricular refractoriness and arrhythmia induction Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1091 - H1096. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arad, I. P. Moskowitz, V. V. Patel, F. Ahmad, A. R. Perez-Atayde, D. B. Sawyer, M. Walter, G. H. Li, P. G. Burgon, C. T. Maguire, et al. Transgenic Mice Overexpressing Mutant PRKAG2 Define the Cause of Wolff-Parkinson-White Syndrome in Glycogen Storage Cardiomyopathy Circulation, June 10, 2003; 107(22): 2850 - 2856. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. I. Berul Electrophysiological phenotyping in genetically engineered mice Physiol Genomics, May 13, 2003; 13(3): 207 - 216. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |